Korean J Infect Dis.  1998 Dec;30(6):564-570.

Group A Streptococcal Infection and Its Present Condition in Korea

Affiliations
  • 1Department of Clinical Pathology, Gyungsang National University School of Medicine, Chinju, Korea.
  • 2Gyungsang Institute of Cancer Research, Gyungsang National University School of Medicine, Chinju, Korea.

Abstract

With introduction of penicillin and improvement of socioeconomic status, severe group A streptococcal (GAS) infections and their sequelae declined dramatically since 1970s. However, there have been worldwide reports on the increase in invasive GAS infections and the resurgence of rheumatic fever since mid-1980s. Necrotizing fasciitis and streptococcal toxic shock syndrome produce marked hypotension and fatal outcome with multiorgan failure. Mortality rate is over 30% in spite of intensive antibiotic treatment and surgical debridement of necrotic tissue. Scarlet fever is not uncommon, but toxic or septic scarlet fever is rare. In Korea poststreptococcal glomerulonephritis (PSGN) is increasing in Chinju city since 1994, while M12, a nephritogenic strain, was more common in Chinju (26.3%) and Seoul (48.8%). Because GAS is very common, highly contagious and cause fatal infections, bacteriological and epidemiologic studies on GAS infections should be continued. With resurgence of rheumatic fever in developed countries, the increasing incidence of PSGN in Chinju area may indicate the need of national surveillance program.

Keyword

Group A streptococci; Rheumatic fever; Necrotizing fasciitis; Streptococcal toxic shock syndrome; Poststreptococcal glomerulonephritis

MeSH Terms

Debridement
Developed Countries
Epidemiologic Studies
Fasciitis, Necrotizing
Fatal Outcome
Glomerulonephritis
Gyeongsangnam-do
Hypotension
Incidence
Korea*
Mortality
Penicillins
Rheumatic Fever
Scarlet Fever
Seoul
Shock, Septic
Social Class
Streptococcal Infections*
Penicillins
Full Text Links
  • KJID
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr